The trend for going natural in treating various chronic medical conditions is growing in recent times. In this connection, CBD and Copaiba oils are two of those natural alternatives that people are looking towards with quite a hope and optimism in treating various medical conditions.
Many favorable studies regarding the health benefits of CBD have been published in recent times. However, there isn’t much research available on Copaiba and most of the information that we have on the therapeutic benefits of these essential oils is based on ancient knowledge and their historical medicinal usages.
Here we would learn about both of these plant-based oils and their respective benefits in treating different ailments.
What is Copaiba? 
Copaiba is an oleoresin belonging to the Copaifera genus of the Fabaceae family. The trees belonging to this genus grow mainly in the Amazon forests in Brazil, South America. The steam distillation of Copaiba produces Copaiba Oil extraction.
Copaiba oil has been in use to derive its therapeutic benefits in South America since ancient times. Like many other essential oils, Copaiba oil also finds its extensive use in aromatherapy as well as in topical applications. Oral usage is also finding its place in the alternative medicine system in recent times.
Beta-caryophyllene (BCP) is the most active substance of Copaiba that is responsible for its medicinal effects. BCP is a type of terpene that interacts with our body system to provide these health benefits.
What is CBD? 
CBD stands for cannabidiol. It belongs to the Cannabis Sativa species of the plants. Hemp and Marijuana plants are the two most popular plants that belong to this species. Both plants contain CBD. The difference, however, lies in the concentration of CBD present in both these plants.
Marijuana has a very low content of CBD while it has a very high percentage of THC. THC is the main compound responsible for the euphoric properties of Marijuana. The hemp plant, however, is CBD rich while having very small traces of THC in it.
Due to this close association between CBD & THC, CBD too, until recently, was perceived to have the same psychoactive properties as THC. However, recent studies on both compounds have objectively concluded that CBD does not possess any psychoactive properties and does not get you high on its consumption.
CBD along with many other compounds like terpenes, phytonutrients, and phenolics provides the health benefits by interacting with different body systems.
The FDA, though has not regulated CBD products in general, it has approved one of the medicines containing CBD with the name Epidiolex for the treatment of Seizures.
Copaiba vs CBD
After learning about the origin of the two compounds you would be wondering- why there is a need to compare these two products.
Well, firstly, because both these oils are plant extracts and offer a few similar health benefits. Secondly and more importantly, with the growing popularity of CBD oil many sellers are promoting Copaiba Oil as the new & more effective CBD Oil.
However, we must be very clear about the fact that CBD and Copaiba oils are very different from each other in most of the aspects including their origin and composition.
So, now we would know about their similarities and differences. Besides, we would also find out which one of the two is better and why.
How do Copaiba and CBD Oil affect our health system?
To understand this we would need to quickly brush up on one of the important body systems influenced by these oils.
The Endocannabinoid System 
The endocannabinoid system (ECS) is a very important system in human physiology that influences many other functions and responses of the human body including motor learning, nervous system, appetite, and perception of pain.
ECS comprises cannabinoid receptors that are located throughout the nervous system to regulate multiple physical processes. These receptors make use of cannabinoids and many enzymes produced by the body in influencing and controlling these physiological processes. So, the endocannabinoid system essentially maintains the harmony of these highly dynamic internal systems.
Now, before moving further, we would understand a bit about the cannabinoid receptors. Both the oils bind with these receptors to provide multiple health benefits.
CB1 and CB2 Receptors 
The Endocannabinoid system comprises two basic cannabinoid receptors viz. CB1 and CB2. The central nervous system contains CB1 receptors while CB2 receptors are predominantly located in our immune system. However, both these receptors are closely related to each other and thus influence the functions of each other.
CB1 receptors can affect our memory, influence pain sensation, and moods quite significantly. Some studies have also found the psychoactive effects of these receptors. CB2, on the other hand, supports mainly our immune system and also influences the nervous system to a great extent.
Depending on the receptor that a cannabinoid would bind to would decide its influence on our body system.
Now, as the endocannabinoid produced by the body bind with these cannabinoid receptors, phytocannabinoids produced by the plants also can connect with them when taken externally.
Therefore, phytocannabinoids like THC, CBD, and BPC present in Copaiba and CBD oil bind with different cannabinoid receptors to provide various health benefits.
THC tends to bind with CB1 receptors and thus gives psychoactive effects. On the other hand, both CBD and BPC bind to the CB2 receptors thus do not give any feeling of euphoria.
Having understood the connection between the human body system and the compounds present in Copaiba and CBD oils lets us now look at some of the benefits offered by both the plant extracts.
Copaiba Oil – Health Benefits 
Copaiba has been in use as traditional or folk medicine in South America for many medical disorders since long. You can orally consume it in the form of oil. However, apart from oral consumption, Copaiba is effectively used in aromatherapy and also in topical applications.
The following are some of these health benefits of Copaiba oil:
Anti-inflammatory and Antiseptic
Copaiba oil is useful in relieving pain & swelling and also in healing cuts & wounds. Some of the studies have shown that it has anti-inflammatory, antiseptic, and pain-relieving properties. The BCP content in the oil is responsible for these properties.
Curing lung ailments
It helps in curing respiratory problems caused by sinusitis and other lung diseases. The age-old medicine can also treat patients suffering from lung cancer.
Improves liver function
It has shown favorable results in improving the functioning of the liver by reducing the damage of the tissue when consumed by mixing it with honey.
Due to the anti-inflammatory properties of the oil, the tropical application of Copaiba has shown positive results in treating skin diseases including acne.
Copaiba oil also finds its use in improving medical conditions related to sleep disorder and has also shown to boost the overall immunity system.
It has shown promising results in treating fever and in alleviating pain caused by fever conditions.
CBD Oil – Health Benefits 
Many clinical studies have shown promising results related to the health benefits of CBD oil. We are presenting below some of those benefits:
The study on 8 seizures patients was conducted for 4 long months. Each of them was administered with a dose of 300mg of CBD. 50% of the participants showed a positive response to the treatment.
This was a big milestone in the journey of CBD and came as a boon for millions of seizures patients across the world.
Clinical studies on animals also have shown optimistic results when rats with temporal seizures were administered a controlled dosage of CBD. They showed a positive effect in curing memory function and also the motor function seriously impacted by their medical condition.
An open-lab study showed promising results of CBD oil in symptomatic relief in patients with autism. All-round improvements were visible and observed in varying degrees in different symptoms including sleep disorders, hyperactivity, and anxiety. However, some mild adverse effects were also observed in the case of anxiety.
A dynamic study showed drastic improvements in the symptoms of autism in children. The study was focused on studying the effects of CBD on symptoms like anxiety and restlessness caused by autism.
Autoimmunity is a medical disorder where your own immune system attacks your body perceiving your own cells as invaders.
Some preclinical studies have indicated that CBD can influence immune cells and suppress them to mitigate their adverse effects on the specific system or the function. CBD can help in increasing MDSCs to regulate T-cells which are responsible for an autoimmune response.
Many clinical studies show effective pain-relieving properties of CBD. This may range from chronic pain to the pain during some serious diseases like cancer or arthritis. However, these results are not essentially with standalone CBD.
Studies on animals have shown positive results in a few preclinical studies related to the inflammation, nerve damage, and arthritis in rats.
The effect of CBD in reducing the breakdown of a particular fatty acid neurotransmitter with the name anandamide has been quite encouraging. Further, its interference with the body receptors has shown to cause the death of cancer cells. More research, though, is needed to establish these facts objectively yet the initial results are pretty encouraging.
Though there is no clinical evidence available on the subject yet some references suggest that pure CBD oil can be very helpful in treating migraines.
Copaiba vs. CBD: The Differences
So, these were the actual or potential benefits of Copaiba and CBD oils. Now, let us understand the difference between the two from different angles.
Hemp and marijuana plants are the two sources of CBD oil. CBD extract derived through hemp would have a high content of CBD and less than 0.3% of THC. Therefore, it does not give you a high. However, CBD oil from marijuana would have a high concentration of THC hence would have psychoactive properties in it.
Depending on the extract, CBD oil either would contain all the compounds present in the plant or would contain all compounds except THC or would not contain any compound other than CBD. The three extracts thus produced are Full spectrum, Broad spectrum or CBD isolates respectively.
The process of CBD extraction is pretty complex and requires close supervision.
Further, CBD oil is not a part of the essential oils.
Copaiba extract is derived from the Copifera trees. The plant does not contain any content of the THC compound.
The extraction process of Copaiba oil is pretty simple. It can be extracted through the steam distillation process from the resin under the bark of the source tree.
Copaiba oil comes in the category of essential oils.
A lot many preclinical and clinical studies are available on the health benefits of CBD oil. However, either most of the studies are conducted on animals or they show the short term effects of CBD on humans.
More extensive research is needed to draw conclusive verdict on humans and particularly its long term benefits.
There has been very limited research available on the health benefits of Copaiba. Most of the research only indicates the composition of Copaiba. At the most, it goes to the extent of the general response of people on its application.
CBD in the CBD oil itself has therapeutic value. Apart from that, it also has many other compounds like THC, terpenes, phytonutrients, and phenolics, etc. In full-spectrum oil all these compounds combine and create entourage-effect. It means, the total effect of all these compounds together is more than the sum total of individual components.
However, it indirectly binds with CB2 receptors of the endocannabinoid system of the body, thus, it can have delayed effects.
BPC is the only compound that provides all the benefits in Copaiba oil. It is a terpene that also enhances the taste & aroma of this oil.
The advantage of BPC over CBD is that BPC directly binds with the CB2 receptor and hence can have quicker effects.
With THC being one of the compounds in a cannabis plant there is always a risk of having THC content in the CBD oil. Therefore there is always a risk of getting high and also of failing a drug test with its consumption.
Moreover, CBD can interact with other medications and can adversely impact the effectiveness of the medications. In certain cases it can have adverse side effects as well.
There is no risk of getting high or failing a drug test, as there are no traces of THC in Copaiba oil. The inputs regarding their interaction with other medications are not available as of now.
Higher dosage of the oil, however, can lead to reactions like vomiting sensation, upset stomach, perspiration and irritation on the skin, etc.
CBD has been legalized in many states across the US. However, the THC content of more than 0.3% is still illegal in most states. And there is always a risk of having higher than allowable limits in CBD. That makes it a little vulnerable from the legal point of view.
Copaiba oil has no chances of having THC or any other psychoactive compound. Therefore, selling and consuming Copaiba is completely legal in the US.
CBD Oil is more expensive than Copaiba Oil. It is mainly because of the complex extraction process. Besides, the legal status of CBD products is still in the gray area that also affects the cost structure of the product.
So, after going through the properties of both the oils, it is pretty clear that both of these products offer many health benefits. They are also similar as both of them are natural plant derivatives.
However, they belong to different families of plants and have entirely different compositions. The difference in their composition also contributes to their respective legal status and also impacts the degree of risk involved in consuming the product.
The two have different extraction processes and that affects their cost of manufacturing and thus the selling price as well.
To sum up, it is still early hours to actually conclude on the comparative utility of these two products showing high potential in providing health benefits. So, we cannot holistically give the final verdict on which one of the two is better.
Having said that, we can definitely infer that both the oils have their distinct advantages and both of them promise to offer a great alternative to traditional medicine in the long run.
If you’re looking to buy CBD oil then we highly recommend checking out these brands before you make a decision to buy.
Reference Resources: Int J Mol Sci. 2018 May; 19(5): 1511./ Published online 2018 May 18./ PMCID: PMC5983702/ PMID: 29783680/ Copaifera of the Neotropics: A Review of the Phytochemistry and Pharmacology/ Rafaela da Trindade,1 Joyce Kelly da Silva,1,2 and William N. Setzer3,4,/ https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5983702/  Wiley Online Library/ Flavors and Fragrances, 4. Natural Raw Materials/ Johannes Panten Horst Surburg/ First published:26 November 2015/ https://onlinelibrary.wiley.com/doi/10.1002/14356007.t11_t03  A Manual of Materia Medica and Pharmacology: Comprising the Organic and Inorganic Drugs which are Or Have Been Recognized by the United States Pharmacopoeia Together with Important Allied Species and Useful Synthetics, Especially Designed for Students of Pharmacy and Medicine, as Well as for Druggists, Pharmacists, and Physicians David Marvel Reynolds Culbreth1 January 1896 Lea & Febiger/ https://play.google.com/store/books/details?id=v6nwAAAAMAAJ&rdid=book-v6nwAAAAMAAJ&rdot=1  MPDI/ Quality Traits of “Cannabidiol Oils”: Cannabinoids Content, Terpene Fingerprint and Oxidation Stability of European Commercially Available Preparations by Radmila Pavlovic 1,2,Giorgio Nenna 3,Lorenzo Calvi 2,Sara Panseri 4,*,Gigliola Borgonovo 5,Luca Giupponi 1,2OrcID,Giuseppe Cannazza 6OrcID andAnnamaria Giorgi 1,2/ https://www.mdpi.com/1420-3049/23/5/1230/htm  NCBI/ Ther Adv Psychopharmacol. 2012 Dec; 2(6): 241–254./ PMCID: PMC3736954/ PMID: 23983983/ Cannabis, a complex plant: different compounds and different effects on individuals/ Zerrin Atakancorresponding author/ https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3736954/  NCBI/ Neurotherapeutics. 2015 Oct; 12(4): 747–768./ Published online 2015 Aug 18. doi: 10.1007/s13311-015-0375-5/ PMCID: PMC4604191/ PMID: 26282273/ Cannabinoids and Epilepsy/ Evan C. Rosenberg,1 Richard W. Tsien,1 Benjamin J. Whalley,2 and Orrin Devinskycorresponding author3/ https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4604191/  NCBI/ Br J Pharmacol. 2010 Jun; 160(3): 523–529./ doi: 10.1111/j.1476-5381.2010.00745.x/ PMCID: PMC2931553/ PMID: 20590562/ Phytocannabinoids beyond the Cannabis plant – do they exist?/ Jürg Gertsch,1 Roger G Pertwee,2 and Vincenzo Di Marzo3/ https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2931553/  NCBI/ Pharmacol Res. Author manuscript; available in PMC 2011 Feb 24./ Published in final edited form as: Pharmacol Res. 2009 Aug; 60(2): 85–92./ Published online 2009 Apr 7. doi: 10.1016/j.phrs.2009.03.019/ PMCID: PMC3044336/ NIHMSID: NIHMS182272/ PMID: 19428268/ Endocannabinoids and immune regulation☆/ Rupal Pandey, Khalida Mousawy, Mitzi Nagarkatti, and Prakash Nagarkatti*/ https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3044336/  NCBI/ Neuropsychopharmacology. 2018 Jan; 43(1): 52–79./ Published online 2017 Nov 8. Prepublished online 2017 Aug 31. doi: 10.1038/npp.2017.204/ PMCID: PMC5719110/ PMID: 28857069/ The Endogenous Cannabinoid System: A Budding Source of Targets for Treating Inflammatory and Neuropathic Pain/ Giulia Donvito,1 Sara R Nass,2 Jenny L Wilkerson,1 Zachary A Curry,1 Lesley D Schurman,1 Steven G Kinsey,2 and Aron H Lichtman1,*/ https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5719110/  NCBI/ J Neurosci. 2006 Aug 23; 26(34): 8829–8837./ doi: 10.1523/JNEUROSCI.1236-06.2006/ PMCID: PMC6674369/ PMID: 16928872/ Endogenous Cannabinoid Signaling through the CB1 Receptor Is Essential for Cerebellum-Dependent Discrete Motor Learning/ Yasushi Kishimoto1,2 and Masanobu Kanocorresponding author1,2/ https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6674369/  ads/ Leptin-regulated endocannabinoids are involved in maintaining food intake/ Di Marzo, Vincenzo; Goparaju, Sravan K.; Wang, Lei; Liu, Jie; Bátkai, Sándor; Járai, Zoltán; Fezza, Filomena; Miura, Grant I.; Palmiter, Richard D.; Sugiura, Takayuki; Kunos, George/ https://ui.adsabs.harvard.edu/abs/2001Natur.410..822D  NCBI/Proc Natl Acad Sci U S A. 2001 Jul 31; 98(16): 9371–9376./ Published online 2001 Jul 24. doi: 10.1073/pnas.161191698/ PMCID: PMC55427/ PMID: 11470906/ Neurobiology/ Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase/ Benjamin F. Cravatt,*† Kristin Demarest,* Matthew P. Patricelli,* Michael H. Bracey,* Dan K. Giang,* Billy R. Martin,‡ and Aron H. Lichtman‡/ https://www.ncbi.nlm.nih.gov/pmc/articles/PMC55427/  Science Direct/ Targeting the endocannabinoid system: future therapeutic strategies/ Author links open/ overlaypanelOierAizpurua-Olaizola1IzaskunElezgarai2IrantzuRico-Barrio2IratxeZarandona1NestorEtxebarria1AresatzUsobiaga1/https://www.sciencedirect.com/science/article/pii/S1359644616302926?via%3Dihub  NCBI/ Mol Pharmacol. 2014 Oct; 86(4): 430–437./ Published online 2014 Oct. doi: 10.1124/mol.114.094649/ PMCID: PMC4164977/ PMID: 25106425/ https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4164977/ CB2 Cannabinoid Receptors as a Therapeutic Target—What Does the Future Hold?/ Amey Dhopeshwarkar and Ken Mackiecorresponding author/ https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4164977/  NIH/ National Library of Medicines/ doi: 10.1016/j.jep.2007.03.005. Epub 2007 Mar 7./ Chemical Composition and Anti-Inflammatory Activity of Copaiba Oils From Copaifera Cearensis Huber Ex Ducke, Copaifera Reticulata Ducke and Copaifera Multijuga Hayne–a Comparative Study/ V F Veiga Junior 1, E C Rosas, M V Carvalho, M G M O Henriques, Angelo C Pinto/ https://pubmed.ncbi.nlm.nih.gov/17446019/  NCBI/ Int J Mol Sci. 2018 May; 19(5): 1511./ Published online 2018 May 18. doi: 10.3390/ijms19051511/ PMCID: PMC5983702/ PMID: 29783680/ Copaifera of the Neotropics: A Review of the Phytochemistry and Pharmacology/ Rafaela da Trindade,1 Joyce Kelly da Silva,1,2 and William N. Setzer3,4,*/ https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5983702/  NCBI/ Biomed Res Int. 2014; 2014: 939738./ Published online 2014 Jun 9. doi: 10.1155/2014/939738/ PMCID: PMC4066724/ PMID: 24999484/ Pleurodesis Induction in Rats by Copaiba (Copaifera multijuga Hayne) Oil/ Fernando Luiz Westphal, 1 ,* Mauro Canzian, 2 Fabio Alessandro Pieri, 3 Alfredo Coimbra Reichl, 1 Paulo Manuel Pêgo-Fernandes, 2 Luis Carlos Lima, 1 and Valdir F. Veiga-Junior 4/ https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4066724/  NIH/ National Library of Medicines/ Acta Cir Bras/ . 2013 Jul;28(7):526-30. doi: 10.1590/s0102-86502013000700008./ Effect of Copaiba Oil in Hepatic Damage Induced by Acetaminophen in Rats/ Renan Kleber Costa Teixeira 1, Vitor Nagai Yamaki, Edson Yuzur Yasojima, Marcus Vinicius Henriques Brito/ Affiliations expand/ PMID: 23842934 DOI: 10.1590/s0102-86502013000700008/ https://pubmed.ncbi.nlm.nih.gov/23842934/  NIH/ National Library of Medicines/ Randomized Controlled Trial Altern Med Rev. 2012 Mar;17(1):69-75. Application of the Essential Oil From Copaiba (Copaifera Langsdori Desf.) for Acne Vulgaris: A Double-Blind, Placebo-Controlled Clinical Trial/ Ary Gomes da Silva 1, Paula de Freitas Puziol, Roane Nunes Leitao, Tatiana Rafaela Gomes, Rodrigo Scherer, Monica Lacerda Lopes Martins, Aurea Scardua Saade Cavalcanti, Luiz Carlos Cavalcanti/ PMID: 22502624/ https://pubmed.ncbi.nlm.nih.gov/22502624/  NIH/ National Library of Medicines/ Review Naturwissenschaften/ . 1978 Apr;65(4):174-9. doi: 10.1007/BF00450585./ Toward Drugs Derived From Cannabis/ R Mechoulam, E A Carlini/ PMID: 351429 DOI: 10.1007/BF00450585/ https://pubmed.ncbi.nlm.nih.gov/351429/  NCBI/ Epilepsia. 2019 Feb; 60(2): 303–314./ Published online 2018 Dec 26. doi: 10.1111/epi.14629/ PMCID: PMC6378611/ PMID: 30588604/ Cannabidiol reduces seizures and associated behavioral comorbidities in a range of animal seizure and epilepsy models/ Pabitra Hriday Patra, 1 , 2 Melissa Barker‐Haliski, 3 H. Steve White, 3 Benjamin J. Whalley, 4 Sarah Glyn, 1 , 2 Haramrit Sandhu, 1 Nicholas Jones, 4 Michael Bazelot, 1 , 4 Claire M. Williams,corresponding author 2 and Alister James McNeishcorresponding author 1/ https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6378611/  NCBI/ Sci Rep. 2019; 9: 200./ Published online 2019 Jan 17. doi: 10.1038/s41598-018-37570-y/ PMCID: PMC6336869/ PMID: 30655581/ Real life Experience of Medical Cannabis Treatment in Autism: Analysis of Safety and Efficacy/ Lihi Bar-Lev Schleider,1,2 Raphael Mechoulam,3 Naama Saban,2 Gal Meiri,4,5 and Victor Novackcorresponding author1/ https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6336869/  NCBI/ Front Immunol. 2018; 9: 1782./ Published online 2018 Aug 3. doi: 10.3389/fimmu.2018.01782/ PMCID: PMC6085417/ PMID: 30123217/ Cannabidiol Attenuates Experimental Autoimmune Encephalomyelitis Model of Multiple Sclerosis Through Induction of Myeloid-Derived Suppressor Cells/ David M. Elliott, Narendra Singh, Mitzi Nagarkatti, and Prakash S. Nagarkatti*/ https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6085417/  NCBI/ Ther Clin Risk Manag. 2008 Feb; 4(1): 245–259./ Published online 2008 Feb. doi: 10.2147/tcrm.s1928/ PMCID: PMC2503660/ PMID: 18728714/ Cannabinoids in the management of difficult to treat pain/ Ethan B Russo/ https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2503660/  NCBI/ Eur J Pain. Author manuscript; available in PMC 2016 Jul 1./ Published in final edited form as: Eur J Pain. 2016 Jul; 20(6): 936–948./ Published online 2015 Oct 30. doi: 10.1002/ejp.818/ PMCID: PMC4851925/ NIHMSID: NIHMS737474/ PMID: 26517407/ Transdermal cannabidiol reduces inflammation and pain-related behaviours in a rat model of arthritis/ D.C. Hammell,1,a L.P. Zhang,2,a F. Ma,2 S.M. Abshire,2 S.L. McIlwrath,2 A.L. Stinchcomb,1 and K.N. Westlund2/ https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4851925/  NCBI/ Pain. 2017 Dec; 158(12): 2442–2451./ Published online 2017 Sep 1. doi: 10.1097/j.pain.0000000000001052/ PMCID: PMC5690292/ PMID: 28885454/ Attenuation of early phase inflammation by cannabidiol prevents pain and nerve damage in rat osteoarthritis/ Holly T. Philpott, Melissa O’Brien, and Jason J. McDougall*/ https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5690292/  NIH/ National Library of Medicines/ Biol Pharm Bull/ . 1996 Aug;19(8):1109-11. doi: 10.1248/bpb.19.1109./ Inhibition of Anandamide Amidase Activity in Mouse Brain Microsomes by Cannabinoids/ K Watanabe 1, Y Kayano, T Matsunaga, I Yamamoto, H Yoshimura/ PMID: 8874830 DOI: 10.1248/bpb.19.1109/ https://pubmed.ncbi.nlm.nih.gov/8874830/  Home News & Events Public Health Focus FDA Regulation of Cannabis and Cannabis-Derived Products, Including Cannabidiol (CBD)/ Content current as of: 03/11/2020/ https://www.fda.gov/news-events/public-health-focus/fda-regulation-cannabis-and-cannabis-derived-products-including-cannabidiol-cbd#farmbill  Department of Health Releases 12 Medical Marijuana Permits for Growers/Processors/ NEWS PROVIDED BY/Pennsylvania Department of Health/Jun 20, 2017, 13:30 ET/HARRISBURG, Pa. /PRNewswire-USNewswire; https://www.prnewswire.com/news-releases/department-of-health-releases-12-medical-marijuana-permits-for-growersprocessors-300476812.html